• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Defining a Hospital Volume Threshold for Minimally Invasive Pancreaticoduodenectomy in the United States.确定美国微创胰十二指肠切除术的医院手术量阈值
JAMA Surg. 2017 Apr 1;152(4):336-342. doi: 10.1001/jamasurg.2016.4753.
2
Comparing Short-term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers.比较低、高容量中心微创与开腹胰十二指肠切除术的短期和肿瘤学结局。
Ann Surg. 2019 Dec;270(6):1147-1155. doi: 10.1097/SLA.0000000000002810.
3
Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer: Practice Patterns and Short-term Outcomes Among 7061 Patients.微创与开放胰十二指肠切除术治疗癌症:7061例患者的实践模式与短期结局
Ann Surg. 2015 Aug;262(2):372-7. doi: 10.1097/SLA.0000000000001055.
4
Determining Hospital Volume Threshold for Safety of Minimally Invasive Pancreaticoduodenectomy: A Contemporary Cutpoint Analysis.确定微创胰十二指肠切除术安全性的医院容量阈值:当代切点分析。
Ann Surg Oncol. 2022 Mar;29(3):1566-1574. doi: 10.1245/s10434-021-10984-1. Epub 2021 Nov 1.
5
Updated Alternative Fistula Risk Score (ua-FRS) to Include Minimally Invasive Pancreatoduodenectomy: Pan-European Validation.更新后的替代瘘管风险评分 (ua-FRS) 纳入了微创胰十二指肠切除术:泛欧验证。
Ann Surg. 2021 Feb 1;273(2):334-340. doi: 10.1097/SLA.0000000000003234.
6
Perioperative textbook outcomes of minimally invasive pancreatoduodenectomy: a multicenter retrospective cohort analysis in a Korean minimally invasive pancreatic surgery registry.微创胰十二指肠切除术的围手术期教科书结局:韩国微创胰腺外科登记处的一项多中心回顾性队列分析。
Int J Surg. 2024 Jul 1;110(7):4249-4258. doi: 10.1097/JS9.0000000000001390.
7
Implementation and outcome of minimally invasive pancreatoduodenectomy in Europe: a registry-based retrospective study - a critical appraisal of the first 3 years of the E-MIPS registry.欧洲微创胰十二指肠切除术的实施和结果:基于注册的回顾性研究——对 E-MIPS 注册处头 3 年的批判性评估。
Int J Surg. 2024 Apr 1;110(4):2226-2233. doi: 10.1097/JS9.0000000000001121.
8
Robotic-assisted versus laparoscopic pancreaticoduodenectomy: oncological outcomes.机器人辅助与腹腔镜胰十二指肠切除术:肿瘤学结果。
Surg Endosc. 2018 Jun;32(6):2907-2913. doi: 10.1007/s00464-017-6002-2. Epub 2017 Dec 26.
9
National Pancreatic Fistula Rates after Minimally Invasive Pancreaticoduodenectomy: A NSQIP Analysis.微创胰十二指肠切除术后全国性胰瘘发生率:一项 NSQIP 分析。
J Am Coll Surg. 2019 Aug;229(2):192-199.e1. doi: 10.1016/j.jamcollsurg.2019.02.042. Epub 2019 Feb 21.
10
Improved outcomes with minimally invasive pancreaticoduodenectomy in patients with dilated pancreatic ducts: a prospective study.微创胰十二指肠切除术治疗胰管扩张患者的疗效改善:一项前瞻性研究。
Surg Endosc. 2022 May;36(5):3100-3109. doi: 10.1007/s00464-021-08611-x. Epub 2021 Jul 7.

引用本文的文献

1
Association of center-level operative volume and acute outcomes following robotic-assisted colectomy for colorectal cancer.机器人辅助结肠癌切除术的中心手术量与急性预后的相关性
PLoS One. 2025 Jun 25;20(6):e0299174. doi: 10.1371/journal.pone.0299174. eCollection 2025.
2
Laparoscopic versus open pancreaticoduodenectomy for pancreatic or periampullary tumors: a multicenter propensity score-matched comparative study.腹腔镜与开放胰十二指肠切除术治疗胰腺或壶腹周围肿瘤:一项多中心倾向评分匹配的比较研究
Surg Endosc. 2025 May;39(5):3037-3048. doi: 10.1007/s00464-025-11677-6. Epub 2025 Mar 25.
3
Laparoscopic versus open pancreatoduodenectomy for periampullary tumors: a randomized clinical trial.腹腔镜与开放胰十二指肠切除术治疗壶腹周围肿瘤:一项随机临床试验。
Int J Surg. 2024 Nov 1;110(11):7011-7019. doi: 10.1097/JS9.0000000000002035.
4
Delayed gastric emptying after laparoscopic pancreaticoduodenectomy: a single-center experience of 827 cases.腹腔镜胰十二指肠切除术后胃排空延迟:单中心 827 例经验。
BMC Surg. 2024 May 11;24(1):145. doi: 10.1186/s12893-024-02447-7.
5
Comparing oncologic and surgical outcomes of robotic and laparoscopic pancreatoduodenectomy in patients with pancreatic cancer: a propensity-matched analysis.比较机器人与腹腔镜胰十二指肠切除术治疗胰腺癌患者的肿瘤学和手术结局:倾向匹配分析。
Surg Endosc. 2024 May;38(5):2602-2610. doi: 10.1007/s00464-024-10783-1. Epub 2024 Mar 18.
6
Robotic versus open partial pancreatoduodenectomy (EUROPA): a randomised controlled stage 2b trial.机器人辅助与开放部分胰十二指肠切除术(EUROPA):一项随机对照2b期试验
Lancet Reg Health Eur. 2024 Feb 22;39:100864. doi: 10.1016/j.lanepe.2024.100864. eCollection 2024 Apr.
7
A novel laparoscopic pancreaticoduodenal training model: optimization of the learning curve and simplification of postoperative complications.一种新的腹腔镜胰十二指肠培训模型:优化学习曲线和简化术后并发症。
Int J Surg. 2024 Feb 1;110(2):758-765. doi: 10.1097/JS9.0000000000000918.
8
Minimally invasive versus open pancreatoduodenectomy for pancreatic and peri-ampullary neoplasm (DIPLOMA-2): study protocol for an international multicenter patient-blinded randomized controlled trial.微创与开腹胰十二指肠切除术治疗胰腺和壶腹周围肿瘤的比较(DIPLOMA-2):一项国际多中心、患者盲法、随机对照临床试验的研究方案。
Trials. 2023 Oct 12;24(1):665. doi: 10.1186/s13063-023-07657-7.
9
Teaching modern pancreatic surgery: close relationship between centralization, innovation, and dissemination of care.教授现代胰腺外科:集中化、创新和护理传播之间的密切关系。
BJS Open. 2023 Sep 5;7(5). doi: 10.1093/bjsopen/zrad081.
10
Management of Patients With Pancreatic Cancer Using the "Right Track" Model.使用“正确轨道”模型管理胰腺癌患者。
Oncologist. 2023 Jul 5;28(7):584-595. doi: 10.1093/oncolo/oyad080.

本文引用的文献

1
Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes?外科医生为优化患者治疗效果应进行的甲状腺切除术是否存在最低数量要求?
Ann Surg. 2017 Feb;265(2):402-407. doi: 10.1097/SLA.0000000000001688.
2
Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: Is This Really a Short Learning Curve?早期国家层面腹腔镜胰十二指肠切除术治疗导管腺癌的经验:这真的是一条短学习曲线吗?
J Am Coll Surg. 2016 Feb;222(2):209. doi: 10.1016/j.jamcollsurg.2015.11.004.
3
The First Decade of Laparoscopic Pancreaticoduodenectomy in the United States: Costs and Outcomes Using the Nationwide Inpatient Sample.美国腹腔镜胰十二指肠切除术的第一个十年:使用全国住院患者样本的成本与结局
Surg Endosc. 2016 May;30(5):1778-83. doi: 10.1007/s00464-015-4444-y. Epub 2015 Aug 15.
4
Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer: Practice Patterns and Short-term Outcomes Among 7061 Patients.微创与开放胰十二指肠切除术治疗癌症:7061例患者的实践模式与短期结局
Ann Surg. 2015 Aug;262(2):372-7. doi: 10.1097/SLA.0000000000001055.
5
Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Comparison of Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy from the National Cancer Data Base.早期全国性腹腔镜胰十二指肠切除术治疗导管腺癌的经验:来自国家癌症数据库的腹腔镜胰十二指肠切除术与开放胰十二指肠切除术的比较
J Am Coll Surg. 2015 Jul;221(1):175-84. doi: 10.1016/j.jamcollsurg.2015.04.021. Epub 2015 Apr 28.
6
Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.对于年龄小于 45 岁的甲状腺乳头状癌患者,淋巴结转移的存在和数量与生存受损有关。
J Clin Oncol. 2015 Jul 20;33(21):2370-5. doi: 10.1200/JCO.2014.59.8391. Epub 2015 Jun 15.
7
The learning curve for robotic distal pancreatectomy: an analysis of outcomes of the first 100 consecutive cases at a high-volume pancreatic centre.机器人辅助远端胰腺切除术的学习曲线:对一家高容量胰腺中心连续100例病例结果的分析。
HPB (Oxford). 2015 Jul;17(7):580-6. doi: 10.1111/hpb.12412. Epub 2015 Apr 23.
8
Assessment of quality outcomes for robotic pancreaticoduodenectomy: identification of the learning curve.机器人胰十二指肠切除术质量结果评估:学习曲线的确定。
JAMA Surg. 2015 May;150(5):416-22. doi: 10.1001/jamasurg.2015.17.
9
Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches?腹腔镜胰十二指肠切除术治疗胰导管腺癌:与开放方法相比的肿瘤学优势?
Ann Surg. 2014 Oct;260(4):633-8; discussion 638-40. doi: 10.1097/SLA.0000000000000937.
10
A comparison of open and minimally invasive surgery for hepatic and pancreatic resections using the Nationwide Inpatient Sample.利用全国住院患者样本对肝脏和胰腺切除术的开放手术与微创手术进行比较。
Surgery. 2014 Sep;156(3):538-47. doi: 10.1016/j.surg.2014.03.046. Epub 2014 Jul 10.

确定美国微创胰十二指肠切除术的医院手术量阈值

Defining a Hospital Volume Threshold for Minimally Invasive Pancreaticoduodenectomy in the United States.

作者信息

Adam Mohamed Abdelgadir, Thomas Samantha, Youngwirth Linda, Pappas Theodore, Roman Sanziana A, Sosa Julie A

机构信息

Department of Surgery, Duke University Medical Center, Durham, North Carolina.

Department of Biostatistics, Duke University, Durham, North Carolina.

出版信息

JAMA Surg. 2017 Apr 1;152(4):336-342. doi: 10.1001/jamasurg.2016.4753.

DOI:10.1001/jamasurg.2016.4753
PMID:28030713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5470427/
Abstract

IMPORTANCE

There is increasing interest in expanding use of minimally invasive pancreaticoduodenectomy (MIPD). This procedure is complex, with data suggesting a significant association between hospital volume and outcomes.

OBJECTIVE

To determine whether there is an MIPD hospital volume threshold for which patient outcomes could be optimized.

DESIGN, SETTING, AND PARTICIPANTS: Adult patients undergoing MIPD were identified from the Healthcare Cost and Utilization Project National Inpatient Sample from 2000 to 2012. Multivariable models with restricted cubic splines were used to identify a hospital volume threshold by plotting annual hospital volume against the adjusted odds of postoperative complications. The current analysis was conducted on August 16, 2016.

MAIN OUTCOMES AND MEASURES

Incidence of any complication.

RESULTS

Of the 865 patients who underwent MIPD, 474 (55%) were male and the median patient age was 67 years (interquartile range, 59-74 years). Among the patients, 747 (86%) had cancer and 91 (11%) had benign conditions/pancreatitis. Overall, 410 patients (47%) had postoperative complications and 31 (4%) died in-hospital. After adjustment for demographic and clinical characteristics, increasing hospital volume was associated with reduced complications (overall association P < .001); the likelihood of experiencing a complication declined as hospital volume increased up to 22 cases per year (95% CI, 21-23). Median hospital volume was 6 cases per year (range, 1-60). Most patients (n = 717; 83%) underwent the procedure at low-volume (≤22 cases per year) hospitals. After adjustment for patient mix, undergoing MIPD at low- vs high-volume hospitals was significantly associated with increased odds for postoperative complications (odds ratio, 1.74; 95% CI, 1.03-2.94; P = .04).

CONCLUSIONS AND RELEVANCE

Hospital volume is significantly associated with improved outcomes from MIPD, with a threshold of 22 cases per year. Most patients undergo MIPD at low-volume hospitals. Protocols outlining minimum procedural volume thresholds should be considered to facilitate safer dissemination of MIPD.

摘要

重要性

扩大微创胰十二指肠切除术(MIPD)的应用越来越受到关注。该手术复杂,数据表明医院手术量与手术结果之间存在显著关联。

目的

确定是否存在一个能使患者手术结果达到最佳的MIPD医院手术量阈值。

设计、设置和参与者:从2000年至2012年的医疗成本和利用项目国家住院样本中识别接受MIPD的成年患者。使用带有受限立方样条的多变量模型,通过绘制年度医院手术量与术后并发症调整后的比值比来确定医院手术量阈值。当前分析于2016年8月16日进行。

主要结局和指标

任何并发症的发生率。

结果

在865例行MIPD的患者中,474例(55%)为男性,患者年龄中位数为67岁(四分位间距,59 - 74岁)。患者中,747例(86%)患有癌症,91例(11%)患有良性疾病/胰腺炎。总体而言,410例患者(47%)出现术后并发症,31例(4%)在住院期间死亡。在对人口统计学和临床特征进行调整后,医院手术量增加与并发症减少相关(总体关联P <.001);随着医院手术量增加至每年22例,发生并发症的可能性下降(95%CI,21 - 23)。医院手术量中位数为每年6例(范围,1 - 60)。大多数患者(n = 717;83%)在低手术量(每年≤22例)医院接受该手术。在对患者构成进行调整后,在低手术量医院与高手术量医院接受MIPD与术后并发症发生几率增加显著相关(比值比,1.74;95%CI,1.03 - 2.94;P =.04)。

结论及相关性

医院手术量与MIPD术后结果改善显著相关,阈值为每年22例。大多数患者在低手术量医院接受MIPD。应考虑制定概述最低手术量阈值的方案,以促进MIPD更安全地推广。